Lekha Nath Panthi, Hom Nath Chalise ABSTRACT In Nepal, though the health service started early, majority of the people are …
EVALUATION OF RENAL FUNCTIONS IN SUDANESE PATIENTS WITH THYROID DISORDERS
Sara Abdalseed Hamed, AbdElkarim A. Abdrabo Background: Thyroid dysfunction causes significant changes in kidney function. Both hypothyroidism and hyperthyroidism affect …
ELUCIDATION OF IRON BINDING PATTERNS THROUGH INSILICO APPROACHES IN HUMAN IRON BINDING PROTEINS
Muthukumaran Sivashanmugam, Anusha Kuppuswamy , Umashankar Vetrivel , K.N. Sulochana Human iron binding proteins play a crucial role in various …
MECHANISM OF ACTION OF ANTI-DIABETIC PROPERTY OF CINNAMIC ACID, A PRINCIPAL ACTIVE INGREDIENT FROM THE BARK OF CINNAMOMUM CASSIA.
Ruchi Tandon , Anurag Gupta, Abhijit Ray Glucose lowering potential of Cinnamon extracts is reported in a variety of studies …
EFFECTS OF DUAL TASK TRAINING ON BALANCE AND COGNITION IN COMMUNITY DWELLING ELDERLY MALES AND FEMALES LIVING IN KANPUR, U.P.
Vanshika Sethi and Shivangi Saxena ABSTRACT Introduction: Aging in its broadest sense is the continuous and irreversible decline in the …
DEVELOPMENT AND CHARACTERIZATION OF NON-IONIC SURFACTANT VESICLES (NIOSOMES) FOR ORAL DELIVERY OF NORFLOXACIN
Akhilesh Dubey, Prabhakara Prabhu Controlled release drug products are often formulated to permit the establishment and maintenance of drug concentration …
EFFECT OF SOLUBILITY OF DIFFERENT EXCIPIENTS ON DRUG RELEASE OF CHITOSAN MATRIX TABLET OF ACECLOFENAC: A STUDY
Ramesh G. Katedeshmukh, Adhikrao V. Yadav Until now numerous oral controlled drug delivery systems have been developed to prolong drug …
ANCIENT AND RECENT MEDICINAL USES OF CUCURBITACEAE FAMILY
Shweta S. Saboo , Priyanka K. Thorat , Ganesh G. Tapadiya , S S. Khadabadi The family Cucurbitaceae includes a …
PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELING OF ANTI-INFLAMMATORY EFFECT OF MELOXICAM, A PREFERENTIAL CYCLOOXYGENASE-2 INHIBITOR, IN RATS
Dheeraj Gopu, Harish Kaushik K, Gomathi P Objective: To establish a suitable Pharmacokinetic / Pharmacodynamic (PK/PD) model for the meloxicams …